Dynamic oxygen-enhanced (OE)-MRI, in combination with dynamic contrast-enhanced (DCE)-MRI, shows use in identifying hypoxic regions in tumours, but relies on an accurate knowledge of baseline (pre contrast-agent administration) tissue characteristics. We present a method of characterising baseline signal drift in an oxygen-enhanced MRI study of preclinical tumour xenografts, where the drift would otherwise impede quantitative analyses. We then demonstrate the utility and necessity of our methods through a comparison of calculated ∆R1 values (reflecting tissue oxygen delivery) with and without our baseline drift correction.
This abstract and the presentation materials are available to members only; a login is required.